January 24, 2022
New Year, New Laws: Drug Price Reform, Coverage Gap, and 340B
4 Minute Read
Potential and pending regulatory changes in 2022 including the current status of the Build Back Better Act and Part D Benefit Design.
Blog
January 20, 2022
IntegriChain and Blue Fin Group Combine Forces
2 Minute Read
Our newly combined team of commercialization experts focuses on solving your biggest access challenges: patient funnel pull-through and GTN optimization.
January 19, 2022
Best Practices: Redesigning the Perfect Launch
3 Minute Read
We ask market access leaders what they would change if they had the ability to launch their therapy all over again.
January 13, 2022
Frequently Asked Questions: Channel and Revenue Leakage
3 Minute Read
We discuss how life sciences manufacturers can maximize profit by reducing revenue leakage through actionable channel data insights.
December 20, 2021
Retail Pharmacy’s Digital Transformation
3 Minute Read
As society shifts toward digital and delivery-based economies, we ask: what will pharmacies look like in the future?
November 23, 2021
A Look Back at the 2021 Access Insights Conference
2 Minute Read
Co-founder and EVP Josh Halpern reviews the recent Access Insights Conference and some of the key challenges that Life Sciences market access teams face.
November 23, 2021
Regulatory Updates
4 Minute Read
This month we discuss COVID-19 vaccine mandates, the recent HHS drug discount ruling, and Medicare drug price reforms.
October 29, 2021
15 Years Strong
2 Minute Read
Founder and CEO Kevin Leininger celebrates IntegriChain's outstanding customers and our team of professionals around the globe on our 15th anniversary.
October 20, 2021
The New Plan for Addressing High Drug Prices
4 Minute Read
We discuss the Biden administration's plan for combatting high drug prices, the new PBM public law reporting cycle, and MA and Part D rule for 2022.